Table 1 Clinical characteristics of paediatric T-ALL cohort (N = 51). *Event = relapse/death/leaving treatment against medical advise
Category (N = 51) | T-ALL (n) | T-ALL (%) |
|---|---|---|
Age (range 1–12 years) | ||
< 5 Years | 11 | 22 |
> 5 years | 40 | 78 |
Gender | ||
Male | 47 | 92 |
Female | 4 | 8 |
WBC (range 26.8–829 × 109/L). | ||
< 50 × 106/L | 4 | 8 |
50–100 × 106/L | 10 | 20 |
> 100 × 106/L | 37 | 72 |
Immunophenotype(N = 47) | ||
Pre-/Pro-TALL | 7 | 15 |
Cortical/Mature | 37 | 79 |
ETP | 3 | 6 |
Day 8 absolute WBC count(N = 43) | ||
> 1000 /ul | 26 | 60 |
< 1000/ul | 17 | 40 |
Relapse | ||
Yes | 9 | 18 |
No | 42 | 72 |
Death | ||
Yes | 7 | 17 |
No | 44 | 83 |
Event* | ||
Yes | 20 | 39 |
No | 31 | 61 |